The novel dihydronaphthyridine Ca2+ channel blocker CI-951 improves CBF, brain pHi, and EEG recovery in focal cerebral ischemia

Fredric B. Meyer, Robert E. Anderson, Thoralf M. Sundt

Research output: Contribution to journalArticlepeer-review

4 Scopus citations

Fingerprint Dive into the research topics of 'The novel dihydronaphthyridine Ca<sup>2+</sup> channel blocker CI-951 improves CBF, brain pH<sub>i</sub>, and EEG recovery in focal cerebral ischemia'. Together they form a unique fingerprint.

Medicine & Life Sciences